We’ve been working towards improving our #colorectalcancer screening rates, and are delighted to share that we've been honored with a national award from the National Colorectal Cancer Roundtable! We are so honored to receive this award, and we are even more proud of our team because they are the ones who focused on these goals. They recognize that early detection gives our patients a chance against colorectal cancer, and their dedication to having these conversations with our patients is so honorable. The #80inEveryCommunity National Achievement Awards is a program designed to recognize individuals and organizations who are dedicating their time, talent and expertise to advancing initiatives that support the shared goal to reach colorectal screening rates of 80% and higher in communities across the nation. The awards include one grand prize winner and four other honorees, each receiving a monetary award to support continued efforts to increase colorectal cancer screenings. Learn more here: https://lnkd.in/gxMFk3k5
Family Health Services’ Post
More Relevant Posts
-
March is Colorectal Cancer Awareness Month. This cause is deeply personal to me, so I’ll be posting about it frequently this month. Please get screened if you are 45 or at greater risk for this disease! To learn more about colorectal cancer, screening, and how you can get involved, visit www.colorectalcancer.org.
-
Founder and CEO at Exhalation Technology Ltd, non-invasive Point of Care diagnostic and screening devices for Lung Cancer, Pneumonia and other respiratory conditions (Semifinalist at EIT Health Catapult)
Early diagnosis using screening programs is crucial to improve the survival rate in lung cancer.
Through our partnership with the WEF EDISON Alliance, we committed to screen 5 million patients through AI-assisted chest X-rays that enable us to optimise and increase lung cancer screening and early detection. By the middle of June this year, we reached the milestone of 2.5 million AI-assisted chest X-rays scans across the world, with our partner Qure.ai and healthcare institutions around the world. While this is a noteworthy milestone to commemorate, a lot more needs to be done to drive a shift towards Lung Cancer detection at earlier stages, hence improving the chance for survival. We call upon on the global oncology community to come together, in a concerted effort to close the Lung Cancer care gap by making Screening & Early Detection a priority.
-
-
Understanding Bladder Cancer Stages: A Comprehensive Guide. Bladder cancer, though a serious condition, is often highly treatable, especially when detected early. In our latest blog authored by Dr. Srivathsan Ramani delves deep into the different types and stages of bladder cancer, providing valuable insights into diagnosis, treatment options, and patient prognosis. At Apollo Proton Cancer Centre (APCC), we emphasize the importance of early detection and a multidisciplinary approach to treatment. Our dedicated team of urologists, oncologists, and radiation oncologists work together to create personalized treatment plans tailored to each patient's needs. Read the full blog here: [https://lnkd.in/gJXz6TMJ] Join us in spreading awareness and knowledge about bladder cancer. Together, we can make a difference! #WinningOverCancer #BladderCancer #CancerAwareness #Healthcare #Oncology #ApolloProtonCancerCentre #APCC
-
-
Did you know that many people with colorectal cancer may not experience symptoms in the early stages? Early detection is key to successful treatment, yet it often goes unnoticed until it's too late. That’s why we're urging everyone to get screened for colorectal cancer today! Don't wait for symptoms to appear. Screening is a powerful tool for preventing colorectal cancer and can save lives. Learn more about early CRC screening by following our new initiative, CONNECT - the Coordinating Center for Colorectal Cancer Screening across Texas. Together, we can combat the second leading cause of cancer-related deaths in Texas. #ColorectalCancerAwareness #EarlyDetection #PreventCRC #DellCONNECT
-
Board Trustee /Director at Tackle Prostate Cancer Past Chair at Tackle prostate cancer Past President ECPC Cancer Patients Coliation Ex President Europa Uomo Chair APPLE Prostate Ex Secretary European Mens Forum
Early diagnosis saves lives and may reduce costs
September is Prostate Cancer Awareness Month! 🎗️💙 Prostate cancer is one of the most common cancers among men, and this month serves as a crucial reminder of the importance of early detection, awareness, and research. At the OPTIMA Project, we are committed to advancing research and innovation in prostate cancer care. Our work is focused on improving the diagnosis, treatment, and management of prostate cancer, striving to offer better care and outcomes for those affected by this disease. Join us in supporting Prostate Cancer Awareness Month by spreading the word, encouraging regular check-ups, and advocating for continued research. Together, we can make a difference in the lives of prostate cancer patients. #ProstateCancerAwareness #OPTIMAProject #HealthcareInnovation #CancerResearch #PatientCare Check out our website to find out more. https://buff.ly/3YQsdOM
-
-
Today is World Lung Cancer Day, a time to raise awareness and support those affected by lung cancer, the leading cause of cancer deaths worldwide. At Freenome, we are developing blood tests to detect lung cancer early, when it is most treatable. The PROACT LUNG Study is intended to validate the clinical performance of a blood-based test for the early detection of lung cancer. We are currently enrolling as many as 20,000 individuals who meet specific criteria. Together, we can drive significant progress in early cancer detection. #WLCD24 #EarlyDetection #Freenome
-
-
Today, on Cancer Survivors Day, and throughout June, Cancer Survivors Month, we honor the courage, resilience, and strength of those who have navigated the cancer journey. This year we mark these occasions by sharing groundbreaking research at #ASCO2024. Our latest studies, on lung cancer patients, investigated the efficacy of personalized drug regimens based on the analysis of 600+ genes. The results were nothing short of transformative, showing a 2.6-fold increase in overall survival and a 3-fold improvement in progression-free survival for patients treated according to Genomate's recommendations. These findings are not just numbers; they represent hope, more moments, and better quality of life for patients and their families. As we share these promising results with the global oncology community, we remain dedicated to delivering on the true promise of personalized oncology. We are proud to be contributing to a future where more patients can say, “I am a survivor.” #CancerSurvivorsDay #CancerSurvivorsMonth #CancerResearch #GenomateHealth
-
Each day, we work to develop meaningful new immunotherapies to improve the treatment of prostate cancer. We also know that early detection is important to better outcomes. Establishing a prostate cancer screening schedule depends on individual risk factors and family history. During Prostate Cancer Awareness Month, we encourage families to discuss their family medical history, and suggest that all the men read up on when to get tested as part of a precision screening process. During #PCAM, we are also proud to participate in the San Diego Run/Walk on September 28th for the ZERO Prostate Cancer patient support network. 💡 Find out when to get checked with this great Prostate Cancer Foundation resource: https://lnkd.in/e4ETdpJq 👟 Sign up for the walk: https://lnkd.in/gcaUhzsX 📚 Learn more about the work we are doing to develop new immunotherapies for #prostatecancer: https://lnkd.in/g7ewWXwB #mCRPC #ZEROout #ProstateCancerAwareness
-
-
Cancer Information Revolutionized: American Cancer Society and American Society of Clinical Oncology (ASCO) Unite to Create Comprehensive Online Resource The American Cancer Society and the American Society of Clinical Oncology (ASCO) have announced a partnership to create one of the largest and most comprehensive online sources of cancer information, accessible for free on cancer.org. This collaboration revealed at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, aims to merge American Cancer Society’s patient education resources with American Society of Clinical Oncology (ASCO)’s expertise in cancer care. It supports the Biden Cancer Moonshot’s goals of reducing cancer mortality and improving patient experiences. This effort is endorsed by key figures like American Cancer Society CEO Karen E. Knudsen, American Society of Clinical Oncology (ASCO) CEO Clifford A. Hudis, and Dr. Danielle Carnival of the Biden Cancer Moonshot. The National Cancer Institute (NCI) also praised the partnership for its potential to offer reliable, timely information amidst the rapid pace of scientific advancement and the proliferation of misleading online content. For more details please click the link! https://lnkd.in/gpqFPN6C #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical
Information and Resources about Cancer: Breast, Colon, Lung, Prostate, Skin
cancer.org
-
🎗️ Shining a Light on Appendiceal Cancer 🎗️ Appendiceal cancer, though rare, is a critical condition that demands our attention and awareness. At TrialNAV, we are committed to supporting research and clinical trials to better understand and treat this unique form of cancer. Why It Matters: ➡️ Rarity and Complexity: Appendiceal cancer is often diagnosed late due to its subtle symptoms and complexity. ➡️ Advancing Treatments: Research is crucial to developing effective treatments and improving patient outcomes. ➡️ Patient Support: Increased awareness can lead to early detection and better support for patients and their families. Join us in raising awareness and supporting the fight against appendiceal cancer. Together, we can make a difference! #AppendicealCancer #CancerResearch #ClinicalTrials #Oncology #PatientSupport #AwarenessMatters
-
